Unique risks for mortality in patients with end-stage renal disease undergoing nonemergent colorectal surgery - 19/06/14
Abstract |
Background |
The aim of this study was to identify unique risk factors for mortality in patients with end-stage renal disease undergoing nonemergent colorectal surgery.
Methods |
A multivariate logistic regression model predicting 30-day mortality was constructed for patients with end-stage renal disease undergoing nonemergent colorectal procedures. Data were obtained from the National Surgical Quality Improvement Program (2005–2010).
Results |
Among the 394 patients analyzed, those with serum creatinine levels >7.5 mg/dL had .07 times the adjusted mortality risk of those with levels <3.5 mg/dL. For colorectal surgery patients, the average serum creatinine level was 5.52 ± 2.6 mg/dL, and mortality was 13% (n = 50).
Conclusions |
High serum creatinine was associated with a lower risk for mortality in patients with end-stage renal disease, even though creatinine is often considered a risk factor for surgery. These results show how variables from a patient-centered subpopulation can differ in meaning from the general population.
Le texte complet de cet article est disponible en PDF.Keywords : American College of Surgeons National Surgical Quality Improvement Program, End-stage renal disease, Colorectal surgery, Mortality, Serum creatinine
Plan
The American College of Surgeons National Surgical Quality Improvement Program and its participating hospitals are the sources of the data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors. |
|
The authors declare no conflicts of interest. |
Vol 208 - N° 1
P. 41-44 - juillet 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?